Sandoz Wins $70M In Antitrust Suit Over Hypertension Drug
By George Woolston · November 4, 2024, 5:25 PM EST
A New Jersey federal court awarded Sandoz Inc. just over $70 million in damages in a case accusing biopharmaceutical firm United Therapeutics Corp. of blocking the sale of a generic version of...
To view the full article, register now.